HubRx appoints Sarah Passmore as superintendent pharmacist


Share post:

HubRx has appointed Dr Sarah Passmore as superintendent pharmacist ahead of launching what the company called “the UK’s first state-of-the-art automated pharmacy hub”.

Dr Passmore brings more than 20 years of pharmacy experience — having held key regulatory roles with Rowlands Pharmacy over a 11-year tenure, which also saw her involved in a number of pharmacy automation projects.

Commenting on her appointment, Dr Passmore said: “As a pharmacist, who has spent more than 10 years working within community pharmacy, I’m excited by what a hub and spoke model for prescription dispensing can bring.

“Pharmacists are highly trained in delivering clinical services to patients – and like me – it’s often a part of their job that they thoroughly enjoy. The option of using hub and spoke to support dispensing prescriptions will give community pharmacists the gift of more time that can be spent helping patients.

“I’m excited to join HubRx and for it to become the first state-of-the-art automated pharmacy hub designed for independent community pharmacists to launch in the UK.”

HubRX says it will free up prescription dispensary time for upwards of 200 independent community pharmacies through a unique hub and spoke model from a state-of-the-art 40,000 sq. ft. fully automated facility. The hub will have the capacity to automate up to 12m healthcare items per year.

HubRx CEO, Daniel Lee, adds: “We’re delighted to welcome Sarah to HubRX. Her experience as a community pharmacist, her background in pharmacy regulation and her knowledge of industry automation means she can combine a professional understanding of the challenges independent pharmacists face with first -hand experience of how technology can provide a solution that maintains patient safety standards.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...